$EW : Heart-device demand drives beat


Sentiment: Positive
'''Edwards Lifesciences beat Q2 estimates on strong demand for heart devices, with shares up nearly 7% in extended trading; it also narrowed its full-year sales outlook while raising the low end of its range. Insight: the combination of demand strength and tighter guidance suggests improving visibility, but the narrowed range implies management is balancing optimism with procedure-volume and mix uncertainty.'''
EW-1.31%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned